- Nessun Dato
Italiano
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
In a study published in Optics Express, the research team led by Professor Fu Yuxi of the Xi'an Institute of Optics and Precision Mechanics (XIOPM) of the Chinese Academy of Sciences developed the room temperature holmium doped lithium yttrium fluoride (Ho: YLF) composite thin slice laser for the first time, which can achieve high efficiency and high-quality CW laser output.Laser devices operating...
Reducing stray light is one of the main challenges in combustion experiments using laser beams (such as Raman spectroscopy) for detection. By using a combination of ultrafast laser pulses and gated ICCD or emICCD cameras, a time filter can be effectively used to remove bright and constant flame backgrounds. When the signal reaches the detector, these cameras can open electronic shutters within the...
Researchers from the Federal Institute of Technology in Zurich and an American startup used slow curing plastic to develop durable and sturdy robots using high-quality materials.The team can now print these complex robots at once and combine soft, elastic, and rigid materials together. This allows for the creation of precision structures and parts with cavities as needed.Inkbit, a derivative compa...
Coherent company's excimer lasers can be more widely used in fusion reactor applications, after the US based photonics giant signed a "letter of intent" with Japan's Faraday 1867 Holdings.Faraday 1867, headquartered in Kanagawa Prefecture, is said to have become the world's leading manufacturer of high-temperature superconducting (HTS) tape through its subsidiary Faraday Japan factory.This tape is...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...